Multidrug resistance related protein (ABCC1) and its role on nitrite production by the murine macrophage cell line RAW 264.7

Biochemical Pharmacology

Volumn 73, Issue 5, 2007, Pages 665-674

  Leite, Daniela F P ^a,b   Echevarria Lima, Juliana ^a,c   Calixto, João B ^b   Rumjanek, Vivian M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c Funda??o Oswaldo Cruz   (Brazil)

Author keywords

ABCC1; Glutathione; Macrophage; Multidrug resistance; Nitric oxide; RAW 264.7

Indexed keywords

ABC TRANSPORTER; BUTHIONINE SULFOXIDE; CARBOXYFLUORESCEIN; CARBOXYFLUORESCEIN DIACETATE; GLUTATHIONE; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MULTIDRUG RESISTANCE PROTEIN 1; NITRITE; PROBENECID; PROTEIN INHIBITOR; SULFUR DERIVATIVE; UNCLASSIFIED DRUG; VERLUKAST;

ANIMAL CELL; ARTICLE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GLUTATHIONE METABOLISM; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ACETYLCYSTEINE; ANIMALS; BUTHIONINE SULFOXIMINE; CELL LINE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTATHIONE; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NITRIC OXIDE SYNTHASE TYPE II; NITRITES;

EID: 33846508615     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.11.005     Document Type: Article

References (46)

1. Borst P., and Elferink R.O. Mammalian ABC transporters in health and disease. Annu Rev Biochem 71 (2002) 537-592
2. Higgins C.F. ABC transporters: from microorganisms to man. Annu Rev Cell Biol 8 (1992) 67-113
3. Prechtl S., Roellinghoff M., Scheper R., Cole S.P., Deeley R.G., and Lohoff M. The multidrug resistance protein 1: a functionally important activation marker for murine Th1 cells. J Immunol 164 (2000) 754-761
4. Robbiani D.F., Finch R.A., Jager D., Muller W.A., Sartorelli A.C., and Randolph G.J. The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103 (2000) 757-768
5. Leite D.F., Echevarria-Lima J., Salgado L.T., Capella M.A., Calixto J.B., and Rumjanek V.M. In vivo and in vitro modulation of MDR molecules in murine thymocytes. Int Immunopharmacol 6 (2006) 204-215
6. de Bittencourt Jr. P.I., Senna S.M., Vidor A.C., Miyasaka C.K., Curi R., and Williams J.F. Glutathione metabolism and glutathione S-conjugate export ATPase (MRP1/GS-X pump) activity in cancer. II. Cell-to-cell variability, relation with cellular activation state and functional absence of GS-X pump in lymphocytes. Biochem Mol Biol Int 45 (1998) 1243-1254
7. Deeley R.G., and Cole S.P. Function, evolution and structure of multidrug resistance protein (MRP). Semin Cancer Biol 8 (1997) 193-204
8. Keppler D., Leier I., and Jedlitschky G. Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol Chem 378 (1997) 787-791
9. Muller M., Meijer C., Zaman G.J., Borst P., Scheper R.J., Mulder N.H., et al. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA 91 (1994) 13033-13037
10. Akimaru K., Nakanishi M., Suzuki M., Furuta K., Noyori R., and Ishikawa T. Cell growth inhibition by antitumor prostaglandin and its modulation by MRP/GS-X pump. Adv Exp Med Biol 407 (1997) 387-391
11. Homem de Bittencourt P.I.J., and Curi R. Antiproliferative prostaglandins and the MRP/GS-X pump role in cancer immunosuppression and insight into new strategies in cancer gene therapy. Biochem Pharmacol 62 (2001) 811-819
12. 2 in MCF7 breast cancer cells. Biochemistry 42 (2003) 5429-5437
13. Forman H.J., and Torres M. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med 166 (2002) S4-S8
14. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43 (1991) 109-142
15. Forman H.J., and Torres M. Redox signaling in macrophages. Mol Aspects Med 22 (2001) 189-216
16. Haddad J.J., Safieh-Garabedian B., Saade N.E., and Lauterbach R. Inhibition of glutathione-related enzymes augments LPS-mediated cytokine biosynthesis: involvement of an IkappaB/NF-kappaB-sensitive pathway in the alveolar epithelium. Int Immunopharmacol 2 (2002) 1567-1583
17. Ferret P.J., Soum E., Negre O., and Fradelizi D. Auto-protective redox buffering systems in stimulated macrophages. BMC Immunol 3 (2002) 1471-1521
18. Kroncke K.D., Fehsel K., Suschek C., and Kolb-Bachofen V. Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival. Int Immunopharmacol 1 (2001) 1407-1420
19. Meister A. Glutathione metabolism and its selective modification. J Biol Chem 263 (1988) 17205-17208
20. Meijer C., Mulder N.H., Timmer-Bosscha H., Peters W.H., and de Vries E.G. Combined in vitro modulation of adriamycin resistance. Int J Cancer 49 (1991) 582-586
21. Akan I., Akan S., Akca H., Savas B., and Ozben T. Multidrug resistance-associated protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and buthionine sulfoximine. Cancer Cell Int 5 (2005) 22-30
22. Depeille P., Cuq P., Passagne I., Evrard A., and Vian L. Combined effects of GSTP1 and MRP1 in melanoma drug resistance. Br J Cancer 93 (2005) 216-223
23. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
24. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
25. Pec M.K., Aguirre A., Fernandez J.J., Souto M.L., Dorta J.F., and Villar J. Dehydrothyrsiferol does not modulate multidrug resistance-associated protein 1 resistance: a functional screening system for MRP1 substrates. Int J Mol Med 10 (2002) 605-608
26. Kalitsky-Szirtes J., Shayeganpour A., Brocks D.R., and Piquette-Miller M. Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats. Drug Metab Disposition 32 (2004) 20-27
27. Kim J.M., Kim H., Kwon S.B., Lee S.Y., Chung S.C., Jeong D.W., et al. Intracellular glutathione status regulates mouse bone marrow monocyte-derived macrophage differentiation and phagocytic activity. Biochem Biophys Res Commun 325 (2004) 101-108
28. Buchmuller-Rouiller Y., Corrandin S.B., Smith J., Schneider P., Ransijn A., Jongeneel C.V., et al. Role of glutathione in macrophage activation: effect of cellular glutathione depletion on nitrite production and leishmanicidal activity. Cell Immunol 164 (1995) 73-80
29. Murphy M.E., Piper H.M., Watanabe H., and Sies H. Nitric oxide production by cultured aortic endothelial cells in response to thiol depletion and replenishment. J Biol Chem 266 (1991) 19378-19383
30. Minghetti L., Nicolini A., Polazzi E., Creminon C., Maclouf J., and Levi G. Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors. Glia 19 (1997) 152-160
31. Chen Y.H., Wang J.P., Wang H., Sun M.F., Wei L.Z., Wei W., et al. Lipopolysaccharide treatment downregulates the expression of the pregnane X receptor, cyp3a11 and mdr1a genes in mouse placenta. Toxicology 211 (2005) 242-252
32. Elferink M.G., Olinga P., Draaisma A.L., Merema M.T., Faber K.N., Slooff M.J., et al. LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am J Physiol Gastrointestinal Liver Physiol 287 (2004) G1008-G1016
33. Cherrington N.J., Slitt A.L., Li N., and Klaassen C.D. Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. Drug Metab Disposition 32 (2004) 734-741
34. Hartmann G., Cheung A.K., and Piquette-Miller M. Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia. J Pharmacol Exp Therapeutics 303 (2002) 273-281
35. Jorajuria S., Dereuddre-Bosquet N., Naissant-Storck K., Dormont D., and Clayette P. Differential expression levels of MRP1, MRP4, and MRP5 in response to human immunodeficiency virus infection in human macrophages. Antimicrob Agents Chemother 48 (2004) 1889-1891
36. Vicente A.M., Guillen M.I., and Alcaraz M.J. Modulation of haem oxygenase-1 expression by nitric oxide and leukotrienes in zymosan-activated macrophages. Br J Pharmacol 133 (2001) 920-926
37. Hui Y., Cheng Y., Smalera I., Jian W., Goldhahn L., Fitzgerald G.A., et al. Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure. Circulation 110 (2004) 3360-3366
38. Ortiz J.L., Gorenne I., Cortijo J., Seller A., Labat C., Sarria B., et al. Leukotriene receptors on human pulmonary vascular endothelium. Br J Pharmacol 115 (1995) 1382-1386
39. Han B., Luo G., Shi Z.Z., Barrios R., Atwood D., Liu W., et al. Gamma-glutamyl leukotrienase, a novel endothelial membrane protein, is specifically responsible for leukotriene D(4) formation in vivo. Am J Pathol 161 (2002) 481-490
40. Kaever V., Pfannkuche H.J., Wessel K., and Resch K. The ratio of macrophage prostaglandin and leukotriene synthesis is determined by the intracellular free calcium level. Biochem Pharmacol 39 (1990) 1313-1319
41. 4 in macrophages exposed to bacterial lipopolysaccharide. Eur J Biochem 155 (1986) 377-382
42. Hulkower K.I., Pollock J.S., Walsh R.E., Huang R., Otis E.R., Brooks C.D., et al. Leukotrienes do not regulate nitric oxide production in RAW 264.7 macrophages. Prostaglandins Leukotrienes Essential Fatty Acids 55 (1996) 145-149
43. Lin W.W., Chang S.H., and Wu M.L. Lipoxygenase metabolites as mediators of UTP-induced intracellular acidification in mouse RAW 264.7 macrophages. Mol Pharmacol 53 (1998) 313-321
44. Watts R.N., Hawkins C., Ponka P., and Richardson D.R. Nitrogen monoxide (NO)-mediated iron release from cells is linked to NO-induced glutathione efflux via multidrug resistance-associated protein 1. Proc Natl Acad Sci USA 103 (2006) 7670-7675
45. Kleinert H., Pautz A., Linker K., and Schwarz P.M. Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 500 (2004) 255-266
46. Kolodziejski P.J., Musial A., Koo J.S., and Eissa N.T. Ubiquitination of inducible nitric oxide synthase is required for its degradation. Proc Natl Acad Sci USA 99 (2002) 12315-12320